VIGLIPTIN-M50/850

VIGLIPTIN-M 50/850 is a combination anti-diabetic tablet containing Vildagliptin 50 mg and Metformin 850 mg, formulated for the effective control of Type 2 Diabetes Mellitus. This dual-action therapy improves insulin response while reducing excess glucose production, helping maintain stable blood sugar levels.

Key Benefits 

✔ Improves glycemic control
✔ Reduces fasting and post-meal blood sugar levels
✔ Enhances insulin secretion naturally
✔ Decreases liver glucose production
✔ Suitable for combination therapy in Type 2 diabetes